Daily BriefsUnited States

Daily Brief United States: AppLovin , Medline, NVIDIA Corp, US Treasury (10 Yr Generic), Cooper Cos, Crude Oil, Doximity, Middleby Corp, Constellation Energy , Intel Corp and more

In today’s briefing:

  • Primer: AppLovin (APP US) – Dec 2025
  • Primer: Medline (MDLN US) – Dec 2025
  • Nvidia Wins Major AI Chip Battle as CEO Jensen Huang Outmaneuvers U.S. Lawmakers; What’s Next?
  • Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%
  • Cooper Cos. Surges as Jana Pushes Merger—Will Bausch + Lomb Strike?
  • Oil futures: Crude drifts as surplus concerns continue to weigh
  • Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year!
  • Middleby Sells Viking Stake: Josh Harris’s Next Billion-Dollar Power Move?
  • Constellation’s Power Grab: Why Buying Calpine Could Change Everything!
  • The Structural Forces Behind Intel’s Supply Squeeze


Primer: AppLovin (APP US) – Dec 2025

By αSK

  • AppLovin is a leading mobile technology company operating a comprehensive platform for app developers to market, monetize, and analyze their applications. Its integrated business model, combining a powerful ad-tech software platform with a portfolio of first-party mobile games, creates a significant data advantage.
  • The company is experiencing hyper-growth, driven by its advanced AI-powered advertising engine, AXON. Financial performance has been exceptional, with substantial year-over-year increases in revenue and a dramatic improvement in profitability and free cash flow generation.
  • Future growth is expected to be fueled by the expansion of its ad platform into non-gaming verticals like e-commerce and Connected TV (CTV), and the global rollout of its self-service ad manager. However, the company faces key risks including intense competition, reliance on the volatile advertising market, and evolving data privacy regulations.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Medline (MDLN US) – Dec 2025

By αSK

  • Medline is a leading manufacturer and distributor of medical-surgical supplies with a vast and resilient supply chain, positioning it as a critical player in the U.S. healthcare system.
  • The company has demonstrated consistent revenue growth, with sales reaching $25.5 billion in 2024, and a significant rebound in profitability, indicating strong operational execution.
  • Following a major leveraged buyout in 2021 by a consortium of private equity firms, Medline is poised for a significant IPO, which is expected to reduce debt and provide capital for further strategic investments and expansion.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Nvidia Wins Major AI Chip Battle as CEO Jensen Huang Outmaneuvers U.S. Lawmakers; What’s Next?

By Baptista Research

  • NVIDIA Corporation reported robust financial performance for the third quarter of fiscal 2026, reflecting its leadership in the AI and accelerated computing markets.
  • The company achieved record revenue of $57 billion, marking a 62% year-over-year increase and a sequential revenue growth of 22%.
  • NVIDIA’s data center segment contributed significantly to this performance, recording $51.2 billion in revenue, up 66% from the previous year.

Rising Yields a Problem?; Russell 2000 Breakout; No Concern if 10Y Treasury Yield Is Below 4.2%

By Joe Jasper

  • We maintain our near-term bullish outlook on S&P 500 (SPX) and Nasdaq 100 (QQQ), which has remained in place since 4/22/25, aside from one week (11/19/25-11/25/25) when we were neutral.
  • Our intermediate-term bullish outlook has been in place since 5/14/25. We’ll stay near-term bullish as long as crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ hold.
  • Additionally, as discussed last week (12/2/25) we believe SPX, QQQ, and Russell 2000 (IWM) are in the midst of a new lockout rally, which is likely to run through early-2026

Cooper Cos. Surges as Jana Pushes Merger—Will Bausch + Lomb Strike?

By Baptista Research

  • Cooper Companies reported its fourth quarter and full year 2025 financial results, highlighting several key aspects across its business segments: CooperVision and CooperSurgical.
  • The company set forth strategic initiatives focusing on market share gains, earnings, free cash flow, and capital return to shareholders.
  • The company reported consolidated revenues of $1.065 billion for the quarter, representing a 4.6% increase year-over-year, with a 3.4% organic growth.

Oil futures: Crude drifts as surplus concerns continue to weigh

By Quantum Commodity Intelligence

  • Crude oil futures were moving sideways on Tuesday as markets steadied after early-week losses, although surplus fears continued to drive sentiment.
  • Front-month Feb26 ICE Brent  futures were trading at  $62.01/b (2000 GMT) versus Monday’s settle of $62.49/b, while Jan26 NYMEX WTI  was at  $58.35/b against a previous close of $58.88/b.
  • Forecasts of a surplus of at least 2 million bpd in the new year continue to weigh heavily on sentiment, despite OPEC+ pausing output hikes in Q1 and the threat to Russian supplies from sanctions.

Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year!

By Baptista Research

  • Doximity, Inc. recently reported its fiscal second-quarter earnings for 2026, highlighting both strides in its growth strategy and existing challenges.
  • Overall, the company demonstrated strong financial performance and operational expansion, positioning itself as a key player in the digital health space, but it also noted some market uncertainties and risks that could impact future performance.
  • On the positive side, Doximity recorded $169 million in revenue, marking a 23% year-over-year increase and exceeding its previous guidance.

Middleby Sells Viking Stake: Josh Harris’s Next Billion-Dollar Power Move?

By Baptista Research

  • Middleby Corp.’s third-quarter performance exhibited both strategic progress and certain challenges that require careful analysis.
  • The company reported total revenues of $980 million, surpassing its guidance range, while adjusted EBITDA reached $196 million and adjusted EPS was $2.37, both exceeding expectations.
  • This performance underscores Middleby’s capacity to leverage its investments in marketing and strategic growth initiatives over the years.

Constellation’s Power Grab: Why Buying Calpine Could Change Everything!

By Baptista Research

  • Constellation Energy Corporation’s third quarter financial performance reflects strong operational execution across its nuclear and energy generation assets.
  • The company reported GAAP earnings of $2.97 per share and adjusted operating earnings of $3.04 per share, an increase compared to the same period last year.
  • This performance was attributed to fewer nuclear outage days and robust generation volumes, though the financial benefits were partially offset by nonrecurring operating and maintenance (O&M) headwinds due to stock compensation plans triggered by the company’s stock appreciation.

The Structural Forces Behind Intel’s Supply Squeeze

By Raghav Vashisht

  • Intel’s supply constraints aren’t manufacturing issues; three independent demand drivers have converged simultaneously, something which the firm seemed to have under-modelled.  
  • Hyperscalers are abandoning their flexible procurement model to secure multi-year CPU commitments for the first time, indicating structural demand shifts rather than temporary spikes.
  • Even TSMC-manufactured Intel products are sold out, proving this is demand-driven across both internal and outsourced capacity.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars